Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [10/07/2025 11:45 PDT] Myomo, Inc. (NYSE:MYO), Up By 100% ($0.87) From $0.87 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [09/26/2025 06:59 PDT] MYO Expected to Trade Up After Bullish Patterns Develop
• [09/22/2025 07:06 PDT] MYO Expected to Trade Up After Bullish Patterns Develop
• [09/12/2025 07:16 PDT] MYO Expected to Trade Down After Bearish Patterns Develop
• [08/14/2025 07:17 PDT] MYO Expected to Trade Down After Bearish Patterns Develop